We are live on ! Find out more
PCP

Pacific Capital Partners Portfolio holdings

AUM $116M
1-Year Est. Return 24.59%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
10 Year Est. Return
AUM
$170M
AUM Growth
-$678K
Cap. Flow
-$21.1M
Cap. Flow %
-12.39%
Top 10 Hldgs %
51.79%
Holding
57
New
3
Increased
17
Reduced
11
Closed
7

Top Buys

Rank Stock Value
1
KBR icon
KBR
KBR
+$6.38M
2
AVTR icon
Avantor
AVTR
+$4.5M
3
CNMD icon
CONMED
CNMD
+$3.83M
4
AMTM
Amentum Holdings
AMTM
+$3.23M
5
ACA icon
Arcosa
ACA
+$2.01M

Top Sells

Rank Stock Value
1
ICLR icon
Icon
ICLR
+$33.6M
2
BWXT icon
BWX Technologies
BWXT
+$5.19M
3
MOH icon
Molina Healthcare
MOH
+$4.31M
4
BLFS icon
BioLife Solutions
BLFS
+$1.82M
5
WWD icon
Woodward
WWD
+$1.28M

Sector Composition

Rank Sector Weight
1 Healthcare 46.16%
2 Industrials 26.99%
3 Financials 9.95%
4 Materials 6.12%
5 Consumer Discretionary 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICUI icon
1
ICU Medical
ICUI
$4.68B
$13.6M 7.99%
87,500
+5,000
+6% +$846K
AVTR icon
2
Avantor
AVTR
$9.44B
$13.2M 7.75%
625,000
+200,000
+47% +$4.5M
CBZ icon
3
CBIZ
CBZ
$2.98B
$9.62M 5.66%
117,500
+5,000
+4% +$374K
UNH icon
4
UnitedHealth
UNH
$349B
$8.36M 4.92%
16,535
+2,500
+18% +$1.42M
CLH icon
5
Clean Harbors
CLH
$17.2B
$8.05M 4.74%
35,000
+5,000
+17% +$1.24M
DHR icon
6
Danaher
DHR
$149B
$8.03M 4.73%
35,000
+6,750
+24% +$1.66M
CRH icon
7
CRH
CRH
$63B
$7.86M 4.63%
85,000
+5,000
+6% +$481K
CNMD icon
8
CONMED
CNMD
$1.54B
$6.92M 4.07%
101,086
+54,888
+119% +$3.83M
WWD icon
9
Woodward
WWD
$21.3B
$6.24M 3.67%
37,500
-7,500
-17% -$1.28M
AER icon
10
AerCap
AER
$23.3B
$6.22M 3.66%
65,000
+15,000
+30% +$1.44M
KBR icon
11
KBR
KBR
$4.79B
$5.79M 3.41%
+100,000
New +$6.38M
ICE icon
12
Intercontinental Exchange
ICE
$88.3B
$5.59M 3.29%
37,500
-5,000
-12% -$792K
ACA icon
13
Arcosa
ACA
$7.13B
$4.84M 2.85%
50,000
+20,000
+67% +$2.01M
ELV icon
14
Elevance Health
ELV
$86.4B
$4.61M 2.71%
12,500
-250
-2% -$105K
PYPL icon
15
PayPal
PYPL
$52.4B
$4.27M 2.51%
50,000
RPRX icon
16
Royalty Pharma
RPRX
$27.5B
$4.15M 2.44%
162,500
BXMT icon
17
Blackstone Mortgage Trust
BXMT
$2.44B
$3.48M 2.05%
200,000
BKNG icon
18
Booking.com
BKNG
$160B
$3.22M 1.89%
16,200
+4,525
+39% +$870K
MET icon
19
MetLife
MET
$60.4B
$2.87M 1.69%
35,000
AMTM
20
Amentum Holdings
AMTM
$5.14B
$2.63M 1.55%
+125,000
New +$3.23M
BWXT icon
21
BWX Technologies
BWXT
$14.9B
$2.51M 1.47%
22,500
-42,500
-65% -$5.19M
FIS icon
22
Fidelity National Information Services
FIS
$21B
$2.42M 1.43%
30,000
ICLR icon
23
Icon
ICLR
$13.3B
$2.23M 1.31%
10,618
-143,820
-93% -$33.6M
PRM icon
24
Perimeter Solutions
PRM
$4.98B
$1.92M 1.13%
+150,000
New +$1.96M
TMO icon
25
Thermo Fisher Scientific
TMO
$227B
$1.88M 1.1%
3,609
+1,251
+53% +$688K

Similar funds

Pacific Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Pacific Capital Partners held 57 positions worth $170M, down 0.4% from $171M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pacific Capital Partners withdrew a net $21.1M in Q4 2024, closing 7 positions and reducing 11 holdings. Its most notable exit was Molina Healthcare, an estimated $4.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 52% a quarter earlier, followed by Industrials and Financials.

Against the trend, Pacific Capital Partners opened a new position in KBR worth $5.79M.

  • Pacific Capital Partners's largest Q4 2024 buy was KBR: 100,000 shares worth $5.79M.
  • Pacific Capital Partners added most to Avantor in Q4 2024, an estimated $4.5M increase.
  • Pacific Capital Partners's biggest Q4 2024 reduction was Icon, cutting an estimated $33.6M.
  • Pacific Capital Partners fully exited Molina Healthcare in Q4 2024, selling an estimated $4.31M.
  • Pacific Capital Partners's ten largest holdings make up 52% of its $170M portfolio in Q4 2024.
  • Pacific Capital Partners opened 3 new positions and closed 7 in Q4 2024.
  • Pacific Capital Partners's portfolio value fell 0.4% quarter-over-quarter to $170M.

Based on Pacific Capital Partners's 13F filing for Q4 2024, filed 8 May 2025.